New Horizons Diagnostics Corporation specializes in the rapid detection of bacteria and toxins across various sectors, including medical, environmental, and food safety. With over 30 years of experience, the company has developed a range of diagnostic tests that facilitate the quick identification of harmful pathogens in human samples, environmental surfaces, food products, and water. Their innovative solutions are designed to support local, national, and international agencies, ensuring that critical health and safety standards are met efficiently.

In addition to their diagnostic capabilities, New Horizons Diagnostics is also involved in the development of therapeutic and preventative agents aimed at treating conditions caused by bacterial and viral infections. Their product offerings include user-friendly rapid test kits that enable agencies and governments worldwide to diagnose and monitor bacterial and toxin presence effectively. This comprehensive approach underscores the company's commitment to enhancing public health and safety through advanced detection technologies.

United States

New Horizons Diagnostic Corporation manufacturesand developsproducts and offers contract services for the medical, diagnostic, environmental and food testing markets. Products include bacteriophage, testing for medically relevant bacteria, collection kits and diagnostic kits for detecting biothreats such as anthrax, cholera, ricin, staph enterotoxin, Yersinapestis, botulism toxin, and tularemia.

New Horizons Diagnostics Corporation

Company Details